Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
3/2/2025
Updated
3/3/25, 7:08 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership